Patent details

EP1646393 Title: A STABLE CLOZAPINE SUSPENSION FORMULATION

Basic Information

Publication number:
EP1646393
PCT Application Number:
PCT/NZ/2004/000158
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047488531
PCT Publication Number:
WO/2005/007168
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A STABLE CLOZAPINE SUSPENSION FORMULATION
French Title of Invention:
FORMULATION DE SUSPENSION STABLE DE CLOZAPINE
German Title of Invention:
STABILE CLOZAPIN-SUSPENSIONSFORMULIERUNG
SPC Number:

Dates

Filing date:
22/07/2004
Grant date:
04/09/2013
EP Publication Date:
04/09/2013
PCT Publication Date:
27/01/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/04/2006
EP B1 Publication Date:
04/09/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/07/2014
Expiration date:
22/07/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/07/2004
 
 

Name:
Douglas Pharmaceuticals Limited
Address:
Central Park Drive, Lincoln, Auckland, New Zealand (NZ)

Inventor

1

Name:
HOULDER-LEVELL Sharon
Address:
New Zealand (NZ)

2

Name:
MCLEOD Andrew Douglas
Address:
New Zealand (NZ)

3

Name:
MAK Wai Bik
Address:
New Zealand (NZ)

4

Name:
SURMAN Peter William
Address:
New Zealand (NZ)

Priority

Priority Number:
52714203
Priority Date:
23/07/2003
Priority Country:
New Zealand (NZ)

Classification

Main IPC Class:
A61K 9/10;
Filing date Document type Number of pages